ETERNITY HEALTHCARE INC.

CIK:0001437822|SEC Filings

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
Income Statement [Abstract]
Sales
Cost of goods sold
Gross margin
Operating Expenses:
General and administrative	182,692	14,691
Total operating expenses	182,692	14,691
Loss from operations	(182,692)	(14,691)
Other expenses:
Interest income/(expense)	1,896	(8,737)
Loss from continuing operations before income taxes	(180,796)	(23,428)
Income tax expense (Note 15)
Loss from continuing operations	(180,796)	(23,428)
Loss from discontinued operations (Note 16)		(83,957)
Net loss	(180,796)	(107,385)
Other comprehensive income/(loss) - Foreign currency translation	7,778	(88,390)
Comprehensive loss	$ (173,018)	$ (195,775)
Net loss per share - basic and diluted
Continuing Operations	$ (0.001)	$ 0
Discontinued operations		(0.001)
Total	$ (0.001)	$ (0.001)
Weighted average number of common shares Outstanding - basic and diluted	171,058,437	70,929,868

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
Operating activities
Net loss	$ (180,796)	$ (107,385)
Loss from discontinued operations, net of income taxes		(83,957)
Net loss for the period from continuing operations	(180,796)	(23,428)
Adjustments to reconcile to net loss to net cash used in continuing operating activities
Amortization of deferred cost	9,337
Interest expense for related party loan		11,250
Changes in operating assets and liabilities:
Other current assets	(5,850)
Other current liabilities	70,369	28
Long-term liabilities	327,726
Net cash provided by/(used in) operating activities of continuing operations	220,786	(12,150)
Net cash used in operating activities of discontinued operations		(22,389)
Net cash provided by/(used in) operating activities	220,786	(34,539)
Investing activities
Credit loan made to third-party borrowers	(256,237)
Repayment from credit loan borrower	158,038
Payments for construction cost	(153,435)
Net cash used in investing activities of continuing operations	(251,634)
Net cash used in investing activities	(251,634)
Financing activities
Repayment of a loan from a third party loan	(31,976)
Proceeds from related party loans	51,179
Net cash provided by financing activities of continuing operations	19,203
Net cash provided by financing activities	19,203
Effect of exchange rate changes on cash	(651)	(10,123)
Net decrease in cash	(12,296)	(44,662)
Cash, beginning of period - continuing operations	21,908
Cash, beginning of period - discontinued operations		148,119
Cash, end of period - continuing operations	9,612
Cash, end of period - discontinued operations		103,457
Supplementary Information
Cash paid for interest
Cash paid for taxes
Supplementary Disclosure of Non-Cash Transaction
Construction in process from payables to vendors	$ 1,656,200

Condensed Consolidated Balance Sheets - USD ($)	Jul. 31, 2018	Apr. 30, 2018
Current assets:
Cash and cash equivalents	$ 9,612	$ 21,908
Deferred cost - current portion (Note 6)	37,349	37,349
Other current assets (Note 4)	116,123	17,970
Total current assets	163,084	77,227
Non-current advanced payments (Note 5)	28,638	30,847
Deferred cost - long-term portion (Note 6)	303,460	312,797
Construction in process (Note 7)	2,224,433	1,538,316
Total assets	2,719,615	1,959,187
Current liabilities:
Interest payable (Note 9)	23,213	12,662
Due to related parties (Note 11)	243,167	191,988
Other current liabilities (Note 8)	1,780,801	1,183,398
Total current liabilities	2,047,181	1,388,048
Long-term loan (Note 9)	454,578	489,631
Long-term liabilities (Note 10)	363,037	53,671
Total liabilities	2,864,796	1,931,350
Commitments (Note 17)
Shareholders' equity
Preferred stock - Authorized 10,000,000 shares, par value $0.001, 0 shares issued and outstanding at July 31, 2018 and April 30, 2018
Common stock - Authorized 1,000,000,000 shares at July 31, 2018 and April 30, 2018, par value $ 0.001, issued and outstanding 171,058,437 shares at July 31, 2018 and April 30, 2018, respectively	171,058	171,058
Additional paid-in capital	3,019,715	3,019,715
Accumulated other comprehensive income/(loss)	6,650	(1,128)
Accumulated deficit	(3,342,604)	(3,161,808)
Total shareholders' (deficit)/equity	(145,181)	27,837
Total liabilities and shareholders' equity	$ 2,719,615	$ 1,959,187